4//SEC Filing
Collins James J. 4
Accession 0000899243-21-023288
CIK 0001680581other
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 5:11 PM ET
Size
10.1 KB
Accession
0000899243-21-023288
Insider Transaction Report
Form 4
Collins James J.
Director
Transactions
- Award
Stock Option (right to buy)
2021-06-09+15,000→ 15,000 totalExercise: $8.85Exp: 2031-06-08→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]This option was granted on June 9, 2021 and is scheduled to vest with respect to all shares on the first anniversary of the grant date or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date, subject to continued service.
Issuer
Fulcrum Therapeutics, Inc.
CIK 0001680581
Entity typeother
Related Parties
1- filerCIK 0001779269
Filing Metadata
- Form type
- 4
- Filed
- Jun 10, 8:00 PM ET
- Accepted
- Jun 11, 5:11 PM ET
- Size
- 10.1 KB